Teclistamab in patients with multiple myeloma and impaired renal function.
Laura JoinerSusan BalKelly N GodbyLuciano José Megale CostaPublished in: American journal of hematology (2023)
Robust anti-myeloma activity with teclistamab in patients with severe renal impairment.
Keyphrases